Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Grant or award Director acquired 923,374 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 238,333 shares (grant or award)
  6. 4 Open-market sale Director sold 100,000 shares at $0.46 ($45,540)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Director acquired 200,000 shares (grant or award)
  12. 4 Open-market buy Member of 10% owner group bought 100,000 shares at $0.28 ($28,000)
  13. 4 Open-market buy Member of 10% owner group bought 200,000 shares at an average $0.29 ($57,380)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Director sold 33,023 shares at $0.28 ($9,246)
  16. 4 Open-market sale Director sold 71,650 shares at an average $0.30 ($21,507)
  17. 4/A Insider Changes in Ownership
  18. 4 Exercise or conversion 10% owner acquired 14,624,999 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 17 · 329 filings